EE9400337A - Pharmaceutical compositions containing interferon alpha and their uses - Google Patents

Pharmaceutical compositions containing interferon alpha and their uses

Info

Publication number
EE9400337A
EE9400337A EE9400337A EE9400337A EE9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
compositions containing
interferon alpha
containing interferon
alpha
Prior art date
Application number
EE9400337A
Other languages
Estonian (et)
Inventor
J. Spiegel Robert
M. Cuss Francis
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of EE9400337A publication Critical patent/EE9400337A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EE9400337A 1990-12-14 1994-11-21 Pharmaceutical compositions containing interferon alpha and their uses EE9400337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14

Publications (1)

Publication Number Publication Date
EE9400337A true EE9400337A (en) 1996-02-15

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400337A EE9400337A (en) 1990-12-14 1994-11-21 Pharmaceutical compositions containing interferon alpha and their uses

Country Status (11)

Country Link
EP (1) EP0563177A1 (en)
JP (1) JPH06503570A (en)
AU (1) AU9139091A (en)
CA (1) CA2098393A1 (en)
EE (1) EE9400337A (en)
IE (1) IE914326A1 (en)
IL (1) IL100332A0 (en)
MX (1) MX9102512A (en)
PT (1) PT99784A (en)
WO (1) WO1992010207A1 (en)
ZA (1) ZA919769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
DK0679718T3 (en) * 1994-04-09 2001-10-22 Hoffmann La Roche Process for the production of alpha interferon
CN1151840C (en) * 1996-05-09 2004-06-02 太平洋制药控股公司 Stimulation of host defence mechanisms against tumors
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
CA2253971A1 (en) * 1996-05-09 1997-11-13 Pharma Pacific Pty.Ltd. Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
WO2004000266A1 (en) * 2002-06-20 2003-12-31 Yuriy Vasilievich Tyagotin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
JPH0647556B2 (en) * 1988-12-01 1994-06-22 シェリング・コーポレーション Treatment of squamous cell carcinoma with recombinant human alpha interferon within the lesion

Also Published As

Publication number Publication date
IE914326A1 (en) 1992-06-17
IL100332A0 (en) 1992-09-06
MX9102512A (en) 1992-06-01
CA2098393A1 (en) 1992-06-15
WO1992010207A1 (en) 1992-06-25
AU9139091A (en) 1992-07-08
EP0563177A1 (en) 1993-10-06
JPH06503570A (en) 1994-04-21
PT99784A (en) 1992-12-31
ZA919769B (en) 1992-09-30

Similar Documents

Publication Publication Date Title
BR1100824A (en) Pharmaceutical composition and composition
FI941747L (en) Compositions and their uses
DE3486441D1 (en) 3-hydroxypyrid-4-one and pharmaceutical compositions
FI922958L (en) PHARMACEUTICAL COMPOSITION
FI981777A7 (en) Pharmaceutical composition
FI922316L (en) PHARMACEUTICAL COMPOSITION
DK1023900T3 (en) Pharmaceutical composition containing S-nitroso-lipoproteins and use thereof
FI925661L (en) INJICERBAR PHARMACEUTICAL COMPOSITION
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
BR9200058A (en) PHARMACEUTICAL COMPOUND AND COMPOSITION
FI953139L (en) Pharmaceutical compositions comprising atovaquone
MX9101035A (en) BIOLOGICALLY ACTIVE QUINAZOLINONES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
FI893643A7 (en) Pharmaceutical compositions
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
MX9200622A (en) PHARMACEUTICAL COMPOSITION
DE4294862T1 (en) Pharmaceutical composition
FI910088A7 (en) Oral pharmaceutical composition
FI934325A7 (en) Insecticide composition and insecticide units
KR900012897A (en) Guanidine derivatives and pharmaceutical compositions containing them
FI960487L (en) Benzopyrans and pharmaceutical compositions containing them
KR890016965A (en) Antibiotic compositions and uses thereof
EE9400337A (en) Pharmaceutical compositions containing interferon alpha and their uses
UA26064A1 (en) PHARMACEUTICAL COMPOSITION
BR8905444A (en) COMPOSITIONS AND APPLICATION
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION